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has health expenditures that ac-
counted for 11.4% of its gross 
domestic product (GDP) in 2012 
— similar to spending levels in 
Canada, France, and Germany (see 
table). Although the Swiss health 
care system is not cheap, its over-
all performance is among the 
best among countries in the Or-
ganization for Economic Cooper-
ation and Development (OECD), 
with high levels of pa-
tient satisfaction and a 
life expectancy that’s 
among the highest in 
the world (similar to those in Ja-
pan and Iceland).1 Nevertheless, 
the system has its challenges.
Switzerland is faring rather 
well economically: its GDP per 
capita is the fourth highest in the 
world, according to the World 
Bank, and its unemployment rate 
is only 3.2%. The country has a 
diverse, international population. 
Almost a quarter (23.8%) of the 
population consists of non-Swiss 
residents; there are four official 
languages. The government has a 
federalist, decentralized structure.
The health system has tradi-
tionally been overseen by the 26 
cantons, which are responsible 
for the planning and delivery of 
health services, partial financing 
of hospitals, and provision of 
subsidies for insurance premiums. 
The central government’s role is 
to issue federal health legisla-
tion, regulate the health insur-
ance market, define the package 
of health care services covered, 
and approve the payment mecha-
nism (mostly fee for service in 
ambulatory care and case-based 
payments [based on diagnosis-
related groups, or DRGs] in inpa-
tient settings). This division of 
responsibilities makes steering 
the system somewhat difficult.
Switzerland’s governance in-
volves direct political participa-
tion, so any changes in health 
policy may be subject to popular 
vote; recent examples include a 
bill on integrated care that en-
couraged the development of 
managed-care organizations and 
a proposal for a single statutory 
health insurance program, both 
of which were rejected. Because 
of this system, policymaking is 
usually pragmatic and consen-
sus-oriented to avoid further de-
lay in processes that are already 
rather lengthy. Health-sector lob-
bying groups with competing in-
terests (those of the pharmaceu-
tical industry, insurers, and health 
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Over the years, the Swiss health care system has repeatedly been mentioned by commentators as 
a potential model for the United States. Switzerland, 
with a permanent resident population of 8 million, 
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care providers) have strong links 
with the National Parliament — 
one reason for the slow pace of 
legislative reforms. Overall, the 
health care sector is seen as a 
flourishing, important, innovative 
industry and a strong motor for 
economic growth and prosperity.
Competition among health care 
providers and payers has an im-
portant place in the design of the 
Swiss health care system. It’s sup-
posed to guarantee high quality 
as well as efficient and cost-effec-
tive service delivery. However, it 
also makes the system prone to 
cartel-like collusion and necessi-
tates strong governmental super-
vision.
There is little explicit rationing 
of services; some studies have 
shown some degree of implicit ra-
tioning, particularly in inpatient 
elderly care services and psychiat-
ric care, and the notion of a “smart-
er medicine” and the motto “less is 
more” have gained considerable 
traction recently. Cost is a concern, 
but there has been no cost explo-
sion; rather, between 1999 and 
2009, the rate of growth in per 
capita health spending has been 
2.0%, below the OECD average 
increase of 4.1% (OECD Review of 
Health Systems Switzerland 2011, 
www.ub.unibas.ch/digi/a125/ 
sachdok/2012/BAU_1_5753611 
.pdf). Accordingly, the health sys-
tem is not perceived as being in 
crisis, although calls for sustain-
ability are receiving increasing at-
tention.
The Swiss population has re-
peatedly voted for retaining con-
sumer choice (e.g., free choice of 
providers and insurers) even if it 
comes at a higher cost. One of 
the main reasons why voters re-
jected the draft law on integrated 
care was concern about losing the 
freedom to choose one’s physi-
cian. Given the vast array of op-
Individual Responsibility and Community Solidarity
Selected Characteristics of the Health Care System and Health Outcomes in Switzerland.*
Variable Value
Health expenditures
Per capita (U.S.$) 8,980
Percentage of GDP 11.3
Out-of-pocket (% of private health expenditures) 73.4
Public sources (% of total) 61.7
Health insurance
Percentage of population covered >98
Source of funding 86% premiums from insured persons; 
14% taxes (premium subsidies)
Average physician income (U.S.$)
Self-employed general practitioner in 2009 185,158
Self-employed specialist in 2009 100,700–388,700  
(depending on specialty)
Generalist–specialist balance in 2014 (%)
Generalists 37.4
Specialists 62.6
Access
No. of hospital beds per 10,000 population in 2011 50
No. of physicians per 1000 population in 2011 3.9
Primary care physicians using electronic medical records (%) 41
Life and death
Life expectancy at birth (yr) 83
Additional life expectancy at 60 yr (yr) 25
Annual no. of deaths per 1000 population 9
No. of infant deaths per 1000 live births in 2013 4
No. of deaths of children <5 yr of age per 1000 live 
births in 2013
4
No. of maternal deaths per 100,000 live births in 2013 6
Fertility and childbirth
Average no. of births per woman 1.5
Births attended by skilled health personnel in 2006 (%) 100
Pregnant women receiving any prenatal care (%) >90
Preventive care
General availability of colorectal-cancer screening at 
primary care level
Yes
Children 12–23 mo of age receiving measles immu-
nization in 2013 (%)
93
Prevalence of chronic diseases (%)
Diabetes in persons 20–79 yr of age in 2013 5.9
HIV infection in 2014 0.4
Prevalence of risk factors (%)
Obesity in adults ≥18 yr of age in 2014 19.4
Overweight in children <5 yr of age NA
Underweight in children <5 yr of age <1.0
Smoking in 2011 26
* Data are from the World Bank, the Swiss Federal Office of Public Health, Schweizerische 
Ärztezeitung, the Organization for Economic Cooperation and Development, the Common-
wealth Fund, the World Health Organization, and indexmundi.com and are for 2012, except 
as noted. GDP denotes gross domestic product, HIV human immunodeficiency virus, and 
NA not available.
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tions, however, patients may find 
it challenging to behave as smart 
consumers who are keen to shop 
for what best meets their wishes 
and needs.
Patients in the Swiss system in-
cur substantial out-of-pocket costs: 
one third of health care spending 
comes from copayments, deduct-
ibles, and other private payments, 
according to the OECD. The pop-
ulation may accept this state of 
affairs because the federal law on 
health insurance that promised 
universal access based on manda-
tory health insurance dates back 
only to 1994 — so unlike coun-
tries with a long tradition of a 
national health service or compre-
hensive social insurance, Switzer-
land faces no historically based 
societal expectation that the state 
or taxpayers will systematically 
cover all health care expenses. 
Indeed, the Swiss government 
has consistently believed that in-
creased cost sharing will improve 
cost awareness and containment.
Despite its market orientation, 
the system depends to a substan-
tial degree on taxpayer funding, 
which accounted for 31% of 
health care spending in 2012. The 
burden of insurance premiums is 
attenuated in two ways: low- and 
middle-income people (37% of the 
population) receive subsidies to 
pay their premiums and to cover 
up to 55% of their hospital bills. 
The coverage provided through 
compulsory, individually purchased 
health insurance is a comprehen-
sive benefit package that is de-
fined by federal authorities. Con-
sumers can choose among various 
models — the standard model or 
any of several managed-care mod-
els, which limit immediate access 
to specialists in exchange for low-
er premiums.
The health insurance market, 
consisting of about 60 companies, 
is supervised by the Federal Of-
fice of Public Health; this office 
must approve insurance premiums, 
which are community-rated. Pro-
posals for a single statutory in-
surance plan have repeatedly been 
voted down, most recently in 
2014.2 Premiums for health in-
surance are not supposed to ex-
ceed 8 to 10% of household in-
come and are subsidized by tax 
money in order to achieve this 
goal. Insurers are not-for-profit 
and have to pay back any surplus 
to their insured population.3
This well-developed public 
component of the Swiss health 
care system reflects an egalitari-
an sentiment that everyone should 
have access to the same good care. 
Social cohesion and solidarity are 
important values shaping public 
Individual Responsibility and Community Solidarity
PREGNANCY AND CHILDBIRTH
A healthy 23-year-old woman is pregnant for the first time.
After Ms. Schifferli takes a home pregnancy test to confirm that 
she’s pregnant, she seeks personal recommendations for a gyne-
cologist. Her mandatory health insurance covers comprehensive 
services for pregnancy, birth, preparatory courses, and breast-feed-
ing advice, as well as midwifery services; a detailed list of reim-
bursed services is available on the website of the Federal Office of 
Public Health. For an uncomplicated pregnancy, there will be seven 
checkups, including two ultrasounds, during pregnancy and another 
checkup 6 to 10 weeks after delivery. There are no deductibles or 
copayments for routine pregnancy care.
In general, services eligible for reimbursement must be effective, 
appropriate, and cost-effective, but homeopathic and traditional 
Chinese medicines, which a friend has recommended for pregnan-
cy-associated discomfort, will probably also be covered by Ms. 
Schifferli’s insurance, thanks to a change made to the Swiss Federal 
Constitution in 2009 regarding complementary medicine. Since Ms. 
Schifferli carries private insurance in addition to her basic benefit 
package, she can expect to have a single room as an inpatient and to 
be seen by a senior physician. When she has her second ultrasound, 
she’s informed about the possibility of prenatal diagnosis, but insur-
ance would not cover it since she’s under 35 and doesn’t have an 
elevated risk of bearing a child with a genetic disease.
Ms. Schifferli can choose from various childbirth settings: the 
university hospital, several city and private hospitals, or her home; a 
local midwife-led birthing center had to close down, since reim-
bursement rates made it unsustainable. Ms. Schifferli attends infor-
mation sessions at various hospitals and is impressed by their hotel-
like amenities — but taken aback to hear a senior physician speaking 
positively about elective caesarean sections, which she’s heard are 
becoming far too common.
After her uncomplicated vaginal delivery at the city hospital close 
to where she lives, Ms. Schifferli is grateful for her midwife’s visits, 
since she’s worried about not having enough milk for the baby. But 
everything turns out to be fine. She receives 14 weeks of paid mater-
nity leave.
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discourse. Marked differences 
in access to care are tolerated 
only with regard to amenities 
such as single-room occupancy 
in hospitals or services such as 
dental care.
The Swiss health care system 
is confronting a number of chal-
lenges. The first is the changing 
demographics of the population: 
the requirements of an aging so-
ciety reinforce the need to provide 
a well-coordinated continuum of 
care, including social services and 
nursing care. Costs are also an is-
sue: in 2013, private nursing care 
cost the country 3.55 billion francs 
(about $3.90 billion). With grow-
ing numbers of women in Swit-
zerland working outside the home, 
the elderly will increasingly need 
to rely on external services. In-
surance for long-term care, how-
ever, is still in its infancy. In ad-
dition, health care personnel are 
becoming increasingly scarce: as 
baby boomers retire in the years 
to come, it will be challenging to 
recruit the personnel to replace 
them. Already, 30% of all physi-
cians working in Switzerland are 
non-Swiss.
Another concern is overtreat-
ment. Because of the comprehen-
sive benefits package of the man-
datory health insurance scheme 
and the high density of health 
care resources, there is evidence 
of supply-induced overconsump-
tion. But highly successful physi-
cian networks, which are becom-
ing increasingly popular, may be 
able to set a new trend, empha-
sizing the compatibility of high-
quality care with responsible 
stewardship of precious public re-
sources. The reports of the Swiss 
Medical Board, a new independent 
health-technology–assessment or-
ganization that provides analysis 
and recommendations on the clin-
ical effectiveness and cost-effec-
tiveness of existing and new in-
terventions, offer helpful reference 
points for medical decisions and 
policy debates. For inpatient care, 
DRGs were introduced into the 
payment system in 2012 as an in-
centive for greater cost-efficiency. 
It remains to be seen, however, 
whether the economic pressure 
perceived by hospital physicians 
will lead to compromises in the 
quality or equity of patient care.4
Third, creating a better data-
base for a learning health care sys-
tem has been identified as an im-
portant step for the future. Current 
evidence on the quality and eq-
uity of health care delivery is still 
patchy; the relevant information 
is neither systematically recorded 
nor uniformly quantified.5 There 
are plans for a large publicly fund-
ed program for health services re-
search, as well as for a national 
network for quality in health care, 
with the goal of improving out-
Individual Responsibility and Community Solidarity
MYOCARDIAL INFARCTION
A 55-year-old man with no other serious health conditions has a moder-
ately severe myocardial infarction.
Feeling unwell, Mr. Aubry leaves work early. When he has severe 
chest pain, shortness of breath, and cold sweats, his wife calls an 
ambulance, which arrives at their suburban home 10 minutes later. 
Ms. Aubry is glad they no longer live in their parents’ village in the 
Alps, although air rescue operates there quite swiftly these days.
The emergency team quickly diagnoses an ST-segment elevation 
myocardial infarction, so Mr. Aubry receives oxygen, aspirin, and 
pain medication and is taken to the nearest catheter laboratory. The 
laboratory has already received the ECG data, and the percutaneous 
coronary intervention (PCI) team is ready to receive the patient. 
Within an hour after the ambulance arrived at his home, Mr. Aubry 
has received several stents.
In a way, Mr. Aubry is lucky because he’s male: in Switzerland, 
7% of men with myocardial infarctions die in the hospital, as com-
pared with 13% of women. The reasons are uncertain and probably 
complex, but it’s known that women reach the hospital an average 
of 80 minutes later than men and are less likely to receive throm-
bolysis or PCI. Overall, the rate of percutaneous revascularization 
has increased significantly, from 6.0% of all patients discharged af-
ter acute myocardial infarction in 1998 to 42.4% in 2006 — provok-
ing debate about the possible overuse of invasive and costly coro-
nary angiography.
After an uncomplicated course of reperfusion therapy, Mr. Aubry 
stays in the hospital for a few days. He begins receiving a combina-
tion of cardiovascular drugs, which his cardiologist and general 
practitioner, both of whom are part of the physician network he’s 
chosen for his regular medical care, are informed about.
Mr. Aubry’s discharge is followed by several weeks of rehabilita-
tion, in which he focuses on reducing cardiovascular risk factors 
primarily by quitting smoking and starting to exercise regularly. 
Three weeks after the event, he is back at work.
The New England Journal of Medicine 
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Individual Responsibility and Community Solidarity
comes and making quality more 
transparent to the public, provid-
ers, and policymakers. Making 
greater use of e-health tools — 
especially electronic medical rec-
ords — is also high on the po-
litical agenda.
Overall, the Swiss health care 
system is costly and has room 
for improvement, particularly in 
terms of accountability for the 
quality, appropriateness, and cost 
of health care services. Yet by 
and large, it has served the Swiss 
population very well. The combi-
nation of “liberalism,” in the 
classic European sense, and soli-
darity — of respecting choice, 
autonomy, and individual respon-
sibility while not letting anyone in 
need of health care suffer or die 
for lack of financial resources 
— seems to work, at least for 
Switzerland.
Disclosure forms provided by the authors 
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Ending the HIV–AIDS Pandemic — Follow the Science
Anthony S. Fauci, M.D., and Hilary D. Marston, M.D., M.P.H.
Related article, p. 2237
In July 1996, researchers, poli-cymakers, and activists in-
volved in the fight against HIV–
AIDS met in Vancouver, Canada, 
for the 11th International Con-
ference on AIDS. During that 
historic meeting, practitioners 
and patients heard evidence re-
garding a powerful weapon to 
stop the relentless onslaught of 
the human immunodeficiency 
virus (HIV): combination anti-
retroviral therapy (ART), with a 
protease inhibitor as the center-
piece of the regimen. In the 
nearly 20 years since that water-
shed meeting, the early promise 
of durable effects from combi-
nation therapy has been realized 
for many patients: between 2000 
and 2014, the rollout of ART 
saved an estimated 7.8 million 
lives worldwide.
Despite this success, the tim-
ing of ART initiation has remained 
the subject of intense debate. As 
with any therapy, clinicians and 
their patients weighed ART’s ben-
efits against its risks, and the re-
sults of that calculus seemed to 
depend on the patient’s stage of 
illness. Specifically, evidence sup-
porting treatment later in the 
course of HIV infection, when 
the CD4+ T-cell count fell below 
a certain critical level, seemed far 
stronger than that supporting 
early treatment (particularly given 
the toxic effects associated with 
the first approved antiretroviral 
drugs). Today, a series of well-de-
signed efficacy studies conducted 
over a period of more than a dec-
ade has fundamentally changed 
this discussion.
In addition, researchers con-
tinue to accrue promising data 
on the concept of using ART for 
HIV prevention in HIV-negative 
persons — preexposure prophy-
laxis (PrEP). Findings from the 
landmark Intervention Préventive 
de l’Exposition aux Risques avec 
et pour les Gays (IPERGAY) study, 
now reported in the Journal (pages 
2237–2246), demonstrate the safe-
ty and efficacy of “on-demand” 
PrEP for men who have sex with 
men and transgender women 
(persons who are born male but 
identify as female), who are at 
high risk for HIV infection. In 
this study, persons who took 
PrEP in an event-driven manner 
around the time of sexual activity 
were 86% less likely to acquire 
HIV infection than those taking 
placebo.
Taken together, these studies 
have shown definitively that the 
benefits of prompt initiation of 
ART — regardless of the CD4+ 
T-cell count — outweigh the risks, 
for both the infected person and 
uninfected sexual partners and 
that PrEP can be implemented 
in a way that is both acceptable to 
patients and safe and effective 
in blocking HIV transmission.
With regard to ART initiation, 
three critical questions were asked 
and answered by a “trifecta” of 
large international randomized, 
controlled trials over the course 
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